Edition:
United Kingdom

People: Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

43.57USD
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
$43.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
771,461
52-wk High
$58.31
52-wk Low
$41.03

Downey, Bruce 

Mr. Bruce L. Downey serves as Independent Director of Cardinal Health Inc. Mr. Downey was Chairman and Chief Executive Officer of Barr Pharmaceuticals, Inc., a global generic pharmaceutical manufacturer, from 1994 to 2008. Mr. Downey has served on a part-time basis as a Partner of NewSpring Health Capital II, L.P., a venture capital firm, since 2009. Having spent 14 years as Chairman and Chief Executive Officer of Barr Pharmaceuticals, Mr. Downey brings to the Board substantial global healthcare experience in the areas of operations, management, regulatory compliance, finance, executive leadership, strategic planning, human resources and corporate governance. He also offers valuable experience in the pharmaceutical and growing international aspects of our businesses, having served as Chief Executive Officer of Barr Pharmaceuticals. Mr. Downey brings to the Board valuable perspective and insights from his service on Momenta Pharmaceuticals’ board of directors, including its Audit Committee, and from his prior service as Chairman of Barr Pharmaceutical's board of directors. Before his career at Barr Pharmaceuticals, Mr. Downey was a practicing attorney for 20 years, having worked in both private practice and with the U.S. Department of Justice.

Basic Compensation

Total Annual Compensation, USD 100,000
Restricted Stock Award, USD 160,000
Long-Term Incentive Plans, USD --
All Other, USD 3,000
Fiscal Year Total, USD 263,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --